| abstract |
The invention relates to a novel membrane serine protease (MT-SP1) whose abundant expression is associated with cancer. In one of its versions, the invention relates to a method for predicting, detecting and determining the stages of cancer in an organism, consisting in taking a biological sample and measuring the level of membrane serine protease (MT-SP1). A high level compared to that of a sample of a normal healthy organism indicates the presence of cancer and its stage. |